Who remembers Martin Shkreli? Increased the price of Daraprim by 5000%!

Archetypal pharma executive

A high net-worth individual, Martin Shkreli, with a stunningly low net-worth moral compass

This piece on Martin Shkreli is taken from the final call to action in FIND IT, FILE IT, FLOG IT: Pharma’s crippling addiction and how to cure it. This is a Tweet from ealier today: https://twitter.com/hedleyrees/status/1653337169937813507?s=20:

“The final call to action

In the latter stages of writing this book, as fate would have it, an event took place that symbolizes all that is awry in this industry.

A high net-worth individual, Martin Shkreli, with a stunningly low net-worth moral compass, ramped up the price of a generic drug his company had acquired by 5,000 percent. Daraprim, one of the many drugs Big Pharma tossed onto the scrap heap years ago, increased in price from $13.50 a tablet to $750.